IL197602A0 - Compositions and methods to prevent cancer with cupredoxins - Google Patents

Compositions and methods to prevent cancer with cupredoxins

Info

Publication number: IL197602A0
Authority: IL; Israel
Prior art keywords: cupredoxins; compositions; methods; prevent cancer; cancer
Prior art date: 2006-09-14

Application number

IL197602A

Original Assignee

Univ Illinois

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-09-14

Filing date

2009-03-15

Publication date

2011-08-01

2009-03-15 Application filed by Univ Illinois filed Critical Univ Illinois

2011-08-01 Publication of IL197602A0 publication Critical patent/IL197602A0/en

Links

206010028980 Neoplasm Diseases 0.000 title 1
201000011510 cancer Diseases 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Enzymes And Modification Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IL197602A 2006-09-14 2009-03-15 Compositions and methods to prevent cancer with cupredoxins IL197602A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US84435806P	2006-09-14	2006-09-14
PCT/US2007/078371 WO2008033987A2 (en)	2006-09-14	2007-09-13	Compositions and methods to prevent cancer with cupredoxins

Publications (1)

Publication Number	Publication Date
IL197602A0 true IL197602A0 (en)	2011-08-01

Family

ID=39184582

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL197602A IL197602A0 (en)	2006-09-14	2009-03-15	Compositions and methods to prevent cancer with cupredoxins

Country Status (13)

Country	Link
EP (1)	EP2061498A4 (en)
JP (2)	JP2010503409A (en)
KR (1)	KR20090059152A (en)
CN (1)	CN101595124A (en)
AU (1)	AU2007296429A1 (en)
BR (1)	BRPI0714987A2 (en)
CA (1)	CA2663498A1 (en)
IL (1)	IL197602A0 (en)
MX (1)	MX2009002787A (en)
NO (1)	NO20091267L (en)
RU (1)	RU2009113812A (en)
SG (1)	SG174784A1 (en)
WO (1)	WO2008033987A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7381701B2 (en)	2001-02-15	2008-06-03	The Borad Of Trustees Of The University Of Illinois	Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US7556810B2 (en)	2005-07-19	2009-07-07	The Board Of Trustees Of The University Of Ilinois	Compositions and methods to control angiogenesis with cupredoxins
US9096663B2 (en)	2001-02-15	2015-08-04	The Board Of Trustees Of The University Of Illinois	Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US9598470B2 (en)	2004-10-07	2017-03-21	Craig W. Beattie	Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
US9968685B2 (en)	2004-10-07	2018-05-15	Brad N. Taylor	Methods to treat cancer with cupredoxins
US10675326B2 (en)	2004-10-07	2020-06-09	The Board Of Trustees Of The University Of Illinois	Compositions comprising cupredoxins for treating cancer
KR20070108128A (en)	2004-10-07	2007-11-08	아난다 차크라바르티	Cupredoxin derived transport agents and methods of use thereof
US9434770B2 (en)	2004-10-07	2016-09-06	Tapas K Das Gupta	Modified cupredoxin derived peptides
KR20080042804A (en)	2005-07-19	2008-05-15	더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이	Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
BRPI0718360A2 (en)	2006-12-04	2013-11-12	Univ Illinois	"COMPOSITIONS AND METHODS FOR CANCER TREATMENT WITH COUPREDOXINS AND RICH DNA IN CPG"
RU2009133473A (en)	2007-02-08	2011-03-20	Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Иллинойс (Us)	COMPOSITIONS AND METHODS FOR PREVENTING CANCER USING CUPREDOXINS
AU2017433280A1 (en) *	2017-09-29	2020-04-16	Oncgnostics Gmbh	Risk determination for neoplasia and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7491394B2 (en) *	2001-02-15	2009-02-17	The Board Of Trustees Of The University Of Illinois	Cytotoxic factors for modulating cell death
CN1506375A (en) *	2002-12-12	2004-06-23	浙江养生堂天然药物研究所有限公司	Azurin as bacterial protein with wide-spectrum antitumor function and its use and medicinal composition
KR20070108128A (en) *	2004-10-07	2007-11-08	아난다 차크라바르티	Cupredoxin derived transport agents and methods of use thereof
AU2006277009A1 (en) *	2005-05-20	2007-02-15	The Board Of Trustees Of The University Of Illinois	Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
WO2007024368A2 (en) *	2005-07-19	2007-03-01	The Board Of Trustees Of The University Of Illinois	Compositions and methods to control angiogenesis with cupredoxins

2007
- 2007-09-13 EP EP07842403A patent/EP2061498A4/en not_active Withdrawn
- 2007-09-13 CN CNA2007800417624A patent/CN101595124A/en active Pending
- 2007-09-13 MX MX2009002787A patent/MX2009002787A/en not_active Application Discontinuation
- 2007-09-13 CA CA002663498A patent/CA2663498A1/en not_active Abandoned
- 2007-09-13 WO PCT/US2007/078371 patent/WO2008033987A2/en active Application Filing
- 2007-09-13 AU AU2007296429A patent/AU2007296429A1/en not_active Abandoned
- 2007-09-13 BR BRPI0714987-5A patent/BRPI0714987A2/en not_active Application Discontinuation
- 2007-09-13 KR KR1020097007352A patent/KR20090059152A/en not_active Application Discontinuation
- 2007-09-13 RU RU2009113812/10A patent/RU2009113812A/en unknown
- 2007-09-13 SG SG2011064334A patent/SG174784A1/en unknown
- 2007-09-13 JP JP2009528468A patent/JP2010503409A/en not_active Withdrawn
2009
- 2009-03-15 IL IL197602A patent/IL197602A0/en unknown
- 2009-03-26 NO NO20091267A patent/NO20091267L/en not_active Application Discontinuation
2013
- 2013-10-04 JP JP2013209725A patent/JP2014050390A/en active Pending

Also Published As

Publication number	Publication date
CA2663498A1 (en)	2008-03-20
WO2008033987A2 (en)	2008-03-20
SG174784A1 (en)	2011-10-28
WO2008033987A3 (en)	2009-04-30
EP2061498A2 (en)	2009-05-27
RU2009113812A (en)	2010-10-20
MX2009002787A (en)	2009-08-27
JP2014050390A (en)	2014-03-20
NO20091267L (en)	2009-06-04
AU2007296429A1 (en)	2008-03-20
KR20090059152A (en)	2009-06-10
JP2010503409A (en)	2010-02-04
EP2061498A4 (en)	2009-11-04
CN101595124A (en)	2009-12-02
BRPI0714987A2 (en)	2013-07-30

Publication	Publication Date	Title
ZA200905508B (en)	2010-07-28	Compositions and methods to prevent cancer with cupredoxins
IL197602A0 (en)	2011-08-01	Compositions and methods to prevent cancer with cupredoxins
ZA201001300B (en)	2010-11-24	Antigen-asjuvant compositions and methods
IL210153A0 (en)	2011-03-31	Nutrigenomics methods and compositions
EP2035014A4 (en)	2009-11-04	Fucoidan compositions and methods
EP2086318A4 (en)	2009-12-23	Neuroprotective compositions and methods
IL212822A0 (en)	2011-07-31	Anti-cxcr1 compositions and methods
EP2101731A4 (en)	2011-04-20	Endoxifen methods and compositions
GB0819530D0 (en)	2008-12-03	Methods and compositions
EP2315600A4 (en)	2012-11-28	Compositions and methods related to sirt1 function
GB0721291D0 (en)	2007-12-12	Methods and compositions
EP2088865A4 (en)	2010-03-17	Guggulphospholipid methods and compositions
GB0617171D0 (en)	2006-10-11	Novel compositions and methods
GB0719526D0 (en)	2007-11-14	Compositions and methods
IL213636A0 (en)	2011-07-31	Compositions and methods to prevent cancer with cupredoxins
GB0713264D0 (en)	2007-08-15	Improvements in and relating to luminaries
GB0615609D0 (en)	2006-09-13	Uses and compositions comprising miRNAs
EP2247303A4 (en)	2011-12-07	Haemostasis- modulating compositions and uses therefor
EP2061493A4 (en)	2011-01-12	Compositions to reduce or prevent skin cancer
IL213657A0 (en)	2011-07-31	Compositions and methods to prevent cancer with cupredoxins
ZA201000357B (en)	2010-09-29	2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
EP2059122A4 (en)	2009-11-11	Methods and compositions related to apobec-1 expression
GB0811250D0 (en)	2008-07-30	Methods and compositions
EP2032146A4 (en)	2010-02-17	Methods and compositions related to tr4
EP2094726A4 (en)	2012-03-28	Compositions and methods related to toll-like receptor-3